Member Info for Adastra

Can't call the exact bottom but I'm sure we're very very close if not there now. Locked, loaded and happy with a £13.30 average.....Happy to wait and have a price target of £16 then £18 as demand accelerates. Not a share I'm going to lose sleep over as the pent up demand is Huge!.

Well that's me locked and loaded up with S&N...
final tranche purchased today giving me an excellent average price to make the most of the upswing when it comes. October lead up to t/u on Nov 4th and increasing traction in surgery gives me confidence. Solid share come what may in the economy. Happy to hold.

T/u is scheduled for 4th Nov but I would appreciate a pre-scheduled comment by the company as happened last year where it was brought forward to Oct 1st. I certainly agree that a variety of factors are now playing into the hands of Smith and Nephew providing the complete opposite of a 'perfect storm'.....golden window?

Got to leap from this ex d level to a sensible £16-18 discounting all possible set backs...too cheap.

S&N is also being totally discounted on this front. Add that to increasingly active surgical activity around the globe as covid effect diminishes and it really does look like a hidden gem in full view! Patience is being stretched but the bounce-back should be very pronounced indeed.....

And yes.....I am still shifting my other stocks to continue loading up here.....just to look oversold.

This should be banging along at £16-18 with the huge backlog of operations ramping up in the next year......mad.....the market is myopic!

How on earth can the market be ignoring the near to medium term value here??? All the indicators have turned positive for surgery ramp-ups, more patients electing to go private plus a huge Malaysian factory due on line next year....FFS..
Cannot get my head round the fall to this level in a near recession proof company ?????

Zimmer reported much improved surgery turnover in August update so should be having traction for S&N. They confirmed update will be announced on 4th Nov so should see uptick as we go forward, plus the xd this week. From Zimmer...

"Our performance in the second quarter improved meaningfully from the first quarter 2021 across all regions and product categories as recovery from the global pandemic continued to take hold. While we anticipate some ongoing COVID-19 pressure, we expect continued improvement in procedure volume recovery through the second half of 2021,"

I should have qualified that I see a £16-18 target within the next 12 months ie by Sept 22 on the basis of the huge pent up demand and surfeit of cash which is being used to fund private operations in non covid centres. Huge upside imo.

Ditto, Smith & Nephew is 40% of my p/f as I've taken profits elsewhere. Average is now 13.45 which I'm comfortable with for all the reasons I've mentioned here. Ex d at end month and happy to hold.....we have parallel aims here. Well oversold with upturn and high side looking strong as ops scale up. Although tabled for Nov 4th I'm expecting a good t/u around Oct 1st as explained in previous posts.

Warren Buffet.....buy when others are fearful.....etc

Agreed, spot on Over us. Let's hope it flies north from here to your upsides.

I give up predicting herd irrationality on this! Patience will prevail despite terse sentiment out there.

At some point very very soon I am sure that sentiment will turn sharply and there will be an institutional scramble to get on board. There is only so far that you can stretch the elastic of incredulity in a share with such a positive future. It's not an old has-been or o&g reliant industry this is a high-tech, high barrier to entry cutting edge company playing to an ever increasing audience. Crazy. Must rerate or be bought out. Private equity and suitors just MUST be tracking it.

Surely 1333 must call the double-bottom that I thought would bounce it at 1350......heyho...still accumulating.

Couldn't agree more. Spire's experience should be being replicated across the globe and I expect the US to be undergoing a particularly strong upswing. Looking forward to the next t/u which cannot come soon enough and reverse this totally illogical dip. When markets are constantly 'looking ahead of events' then Smith & Nephew has been totally ignored. A rapid reversal and gap-jumps must surely be imminent.....hugely oversold at present. True value is £16-18 not £13-14 at this time.

Bye bye £13.50..... never to be revisited. Bot trading has set the floor. Onward and upward in the race to get on board....

Lots of upside for a quality stock with no bid premium at this level.....

Fully loaded now for the huge rise I'm expecting now